Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

EMORY UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1836-12-10

Employees: 10K

Market Cap: -

Website: http://www.emory.edu

Clinical Trials

Comprehensive Esophageal Diagnostics Study

Phase 4

Recruiting

Conditions: Achalasia

Interventions: Drug: Atropine challenge
Procedure: Esophageal muscle biopsy

First Posted Date: 2020-11-24

Last Posted Date: 2024-07-15

Lead Sponsor: Emory University

Target Recruit Count: 80

Registration Number: NCT04641702

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States
🇺🇸
Emory Saint Joseph's Hospital, Atlanta, Georgia, United States

A Pragmatic Trial of HOBSCOTCH in Georgia

Not Applicable

Completed

Conditions: Epilepsy

Interventions: Behavioral: HOBSCOTCH

First Posted Date: 2020-11-20

Last Posted Date: 2025-02-25

Lead Sponsor: Emory University

Target Recruit Count: 93

Registration Number: NCT04639206

Locations: 🇺🇸
Emory Brain Health Center, Atlanta, Georgia, United States

Building Adaptive Coping and Knowledge to Improve Daily Life

Not Applicable

Completed

Conditions: Sickle Cell Disease

Interventions: Behavioral: Back2Life

First Posted Date: 2020-10-26

Last Posted Date: 2025-06-29

Lead Sponsor: Emory University

Target Recruit Count: 40

Registration Number: NCT04602728

Locations: 🇺🇸
Children's Healthcare of Atlanta at Hughes Spalding, Atlanta, Georgia, United States
🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
🇺🇸
Emory Children's Center, Atlanta, Georgia, United States

Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma

Phase 1

Recruiting

Conditions: Glioblastoma
Recurrent Glioblastoma

Interventions: Drug: Verteporfin

First Posted Date: 2020-10-19

Last Posted Date: 2025-02-25

Lead Sponsor: Emory University

Target Recruit Count: 24

Registration Number: NCT04590664

Locations: 🇺🇸
Emory University Hospital/Winship Cancer Institute, Atlanta, Georgia, United States

Stereotactic Radiosurgery With Abemaciclib, Ribociclib, or Palbociclib in Treating Patients With Hormone Receptor Positive Breast Cancer With Brain Metastases

Phase 1

Withdrawn

Conditions: Metastatic Breast Carcinoma
Anatomic Stage IV Breast Cancer American Joint Committee on Cancer (AJCC) v8
Metastatic Malignant Neoplasm in the Brain
Prognostic Stage IV Breast Cancer AJCC v8

Interventions: Drug: Abemaciclib
Drug: Palbociclib
Other: Quality-of-Life Assessment
Drug: Ribociclib

First Posted Date: 2020-10-14

Last Posted Date: 2021-10-18

Lead Sponsor: Emory University

Registration Number: NCT04585724

Eye-Control Trial: Wearable Eye-Tracking Device as Means of Communication

Not Applicable

Completed

Conditions: Acute Respiratory Failure Requiring Mechanical Ventilation

Interventions: Device: EyeControl Eye-tracking Device

First Posted Date: 2020-10-09

Last Posted Date: 2024-02-14

Lead Sponsor: Emory University

Target Recruit Count: 30

Registration Number: NCT04582149

Locations: 🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

TBI Evaluation and Management (TEaM)

Not Applicable

Recruiting

Conditions: Mild Traumatic Brain Injury

Interventions: Behavioral: TEaM Intervention
Behavioral: Standard of Care

First Posted Date: 2020-10-06

Last Posted Date: 2025-02-25

Lead Sponsor: Emory University

Target Recruit Count: 1000

Registration Number: NCT04576715

Locations: 🇺🇸
Children's Healthcare of Atlanta (CHOA) - Egleston Emergency Department, Atlanta, Georgia, United States
🇺🇸
Children's Healthcare of Atlanta- Forsyth, Northpoint and Town Center Urgent Care Centers, Atlanta, Georgia, United States
🇺🇸
Children's Healthcare of Atlanta- Primary Care Offices, Atlanta, Georgia, United States

Percutaneous CT-guided Cryoablation of the Splanchnic Nerves

Not Applicable

Withdrawn

Conditions: Type 2 Diabetes

Interventions: Device: CT Guided Splanchnic Cryoablation

First Posted Date: 2020-09-30

Last Posted Date: 2021-07-28

Lead Sponsor: Emory University

Registration Number: NCT04569721

Locations: 🇺🇸
Emory Johns Creek Hospital, Johns Creek, Georgia, United States

SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis

Phase 3

Recruiting

Conditions: Hemophilia A

Interventions: Drug: Emicizumab
Drug: FEIBA
Drug: rFVIIa

First Posted Date: 2020-09-24

Last Posted Date: 2025-05-14

Lead Sponsor: Emory University

Target Recruit Count: 5

Registration Number: NCT04563520

Locations: 🇺🇸
Children's Healthcare of Atlanta, Atlanta, Georgia, United States
🇺🇸
Emory University Hospital, Atlanta, Georgia, United States

Effect of TMS on PTSD Biomarkers

Not Applicable

Active, not recruiting

Conditions: Post Traumatic Stress Disorder

Interventions: Device: Transcranial Magnetic Stimulation (TMS)
Procedure: Sham Transcranial Magnetic Stimulation (TMS)

First Posted Date: 2020-09-24

Last Posted Date: 2025-06-19

Lead Sponsor: Emory University

Target Recruit Count: 63

Registration Number: NCT04563078

Locations: 🇺🇸
Grady Hospital, Atlanta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy